NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2020 – Has Sufficient Cash, Coronavirus Drug Candidate Safe in GLP Safety Toxicology Moving Towards IND
SHELTON, CT / ACCESSWIRE / February 17, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in...